Genetic screens in mice for genome integrity maintenance and cancer predisposition

Gabriel Balmus1, Rebecca E McIntyre2

  • 1The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Insights

Genome instability is a hallmark of cancer and linked to developmental disorders. Understanding its genetic network, particularly in mice, aids cancer therapy and developmental biology research.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Developmental Biology

Background:

  • Genome instability is a common characteristic of human cancers.
  • Defects in genome maintenance genes are linked to various developmental disorders.
  • A deeper understanding of the genetic network governing genome stability is crucial.

Purpose of the Study:

  • To review recent genetic screens in model organisms for novel genome stability regulators.
  • To emphasize the utility of mice as a model for studying genome instability.
  • To explore the role of genome instability in embryonic development, tumorigenesis, and cancer treatment.

Main Methods:

  • Review of recent genetic screens in model organisms.
  • Focus on studies utilizing the mouse model system.

Main Results:

  • Genetic screens have identified new regulators of genome stability.
  • Mice serve as a valuable model for investigating genome instability's impact.
  • Insights gained contribute to understanding cancer development and therapy.

Conclusions:

  • Understanding genome stability networks is vital for both developmental disorders and cancer.
  • Model organisms, especially mice, are instrumental in advancing this field.
  • Further research in this area holds promise for therapeutic strategies.